Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way

Detalles Bibliográficos
Autores principales: Chaves, Otávio Augusto, Sacramento, Carolina Q, Fintelman-Rodrigues, Natalia, Temerozo, Jairo Ramos, Pereira-Dutra, Filipe, Mizurini, Daniella M, Monteiro, Robson Q, Vazquez, Leonardo, Bozza, Patricia T, Castro-Faria-Neto, Hugo Caire, Souza, Thiago Moreno L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492308/
https://www.ncbi.nlm.nih.gov/pubmed/35759391
http://dx.doi.org/10.1093/jmcb/mjac039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492308/
https://www.ncbi.nlm.nih.gov/pubmed/35759391
http://dx.doi.org/10.1093/jmcb/mjac039

Ejemplares similares